LifeVantage Corporation (Nasdaq: LFVN) reported revenue of $56.2 million for its first quarter ended September 30, 2019.
Revenue increased 1.1 percent from $55.6 million in the first quarter of fiscal 2019. Revenue in the Americas decreased 2.2 percent, while revenue in Asia/Pacific & Europe increased 10.4 percent. Total active accounts decreased 2.2 percent to 181,000, including a 1.5 percent decline of independent distributor and a 2.5 percent decline in active customers;
“We are off to a strong start to fiscal 2020, generating 45 percent year-over-year growth of adjusted EBITDA and 86 percent adjusted EPS growth over the prior year period,” stated LifeVantage President and Chief Executive Officer Darren Jensen. “We continue to focus on driving revenue growth through execution of our key initiatives. A significant driver of our 2020 growth goals revolves around the early October launch of Protandim® NAD Synergizer. This recent addition to our flagship Protandim® product line has received a strong response across our customer base and to date has been one of our most successful new product launches in company history.”
To see the full Q1 2020 report, click here.